Global health program.

Political instability and conflict can be obstacles to progress in health welfare programs.

Political instability can also result in gaps in governance, diversion of funding and implementation difficulties, such as disruption of infrastructure, limited access to local populations and risks to the health workers.

Migration and other population displacement can result in or re-entry of disease, particularly when displaced persons live in temporary accommodation with inadequate sanitation, poor water storage, and limited access to health centers.

Local epidemics or pandemics can significantly limit the implementation of interventions during an outbreak.

Climate change is changing the epidemiology of vector-borne diseases and the spread of diseases such as dengue fever and chikungunya.

Antimicrobial and insecticide resistance are emerging threats for certain diseases, especially considering the use of insecticides for vector control.

These challenges highlight the importance of new and innovative approaches, such as the development of new antimicrobials and systems for monitoring antimicrobial resistance.

Contingency planning will be important to reduce the effects of unforeseen events. Collaboration with government actors such as environmental policymakers and migration authorities will be essential to reduce risks to achieve the 2030 target.

Each disease will require a unique set of actions to meet milestones and targets. Although certain themes are relevant to many diseases, a critical set of actions will be required for each disease and group of diseases.

These groups of diseases and diseases and the responses that are needed must involve not only the health system but also the wider public and private sectors.

Certain psychosocial and neurological effects cannot be managed without well-functioning mental health and social support structures.

Programs should include interventions aimed at reducing stigmatization and reducing barriers to access to care and treatment for marginalized individuals, families, communities and groups, such as migrants.

such as the WHO's Global Plan to Combat Neglected Tropical Diseases in 2008-2015 and the actions advocated by the World Health Assembly in resolution WHA66.12 (2013) on neglected tropical diseases, so far these programs have remained largely disease specific.

One of its aims is to encourage a shift to cross-sectoral work, by providing a clear framework and proposing concrete strategies and actions.

Most of the cross-cutting measures recommended are based on country best practice.

Not all will be applicable in every country, but, together, they represent a comprehensive guide of action.

Research and innovation are fundamental drivers of programmatic progress for all diseases

Research, development and innovation are essential to find the right solution to all diseases during the program.

Baseline research, operations and implementation are needed to answer a variety of questions and to establish baseline prevalence of a disease and determine when to stop mass drug administration (MDA).

Therefore, research and development of new treatment interventions, diagnostics, tools and approaches should be supported, in collaboration with other stakeholders, in ways that include product development partnerships (e.g. Drugs for Neglected Diseases initiative and the Foundation for Innovative New Diagnostics) .

Research is needed on the behavioral and social aspects of the needs and perceptions of society in increasing treatment adherence and healthy behavior in the context.

In some countries, digital health applications may be formal programs or directorates within the ministry of health, while in other countries they may be represented by less formal structures such as task forces or national coordinating bodies.

An integrated health platform will promote a broader and more holistic approach to include not only prevention but also treatment, care, rehabilitation and health education.

Diseases such as scabies and yaws should be included in existing integrated preventive programs, which are usually limited to one group of five diseases.

In addition, more work is needed to integrate operations against disease with similar treatment measures, epidemiology and geographic distribution.